Downregulation of SLC7A11 disrupts cysteine metabolism, leading to decreased intracellular cystine and GSH levels, impairing GPX4 activity and triggering lipid peroxide accumulation and ferroptosis (79,81,82)
Florida Medicaid also does not cover GLP-1s for obesity
What to monitor during treatment Whether you are on the standard or enhanced protocol, monitoring ensures safety and allows dose adjustments: Weight: Weekly, same time and conditions Energy levels: Daily subjective rating GI symptoms: Daily during titration, weekly at maintenance Blood work (every 3 months): Complete metabolic panel, fasting glucose, HbA1c, liver enzymes, lipid panel, B12, folate Injection sites: Monitor for redness, lumps, or persistent reactions If you notice persistent fatigue despite the niacinamide compound, discuss with your provider whether adjusting your overall approach might be warranted
BMJ 386 , q1645 (2024)
Day-to-night longevity support
August 1998